← My Government dashboard

Government Watch

Dossier Executive final rule 10-sep-2026 Takes effect · 10-sep-2026 · 61 days ago
Finalized regulation — legally enforceable once its effective date arrives.

Medical Devices; Cardiovascular Devices; Classification of the Temperature Regulation Device for Esophageal Protection During Cardiac Ablation Procedures

Key claim: FDA is putting esophageal temperature-regulation devices used during cardiac ablation into class II, so they can be marketed under specified special controls instead of the stricter class III process.

Abstract

(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the temperature regulation device for esophageal protection during cardiac ablation procedures into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the temperature regulation device for esophageal protection during cardiac ablation procedures. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.

Why this matters

Down-classifying this esophageal protection accessory from Class III to Class II lowers the regulatory bar for manufacturers to bring temperature-regulation devices used during cardiac ablation to market via 510(k), which can broaden clinician access to esophageal-injury mitigation tools during atrial fibrillation ablations. The change is narrow in scope but fits a broader FDA pattern of routine Class II classifications for niche cardiovascular accessories.

Source

Link

Briefing card

Medical Devices; Cardiovascular Devices; Classification of the Temperature Regulation Device for Esophageal Protection During Cardiac Ablation Procedures
Stage: final rule · federal-register · 10-sep-2026

If you're scheduled for cardiac ablation, this rule makes it easier for manufacturers to market esophageal temperature-regulation devices used to reduce heat injury during the procedure.

FDA is putting esophageal temperature-regulation devices used during cardiac ablation into class II, so they can be marketed under specified special controls instead of the stricter class III process.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: fedreg:2026-18432

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

Stages other doctrine resolution introduced proposed rule passed chamber executive action final rule enacted district opinion circuit opinion opinion

build build 600 · dacf81d · 2026-11-09